CM
CM Management Portfolio holdings
AUM
$157M
Turnover
30.95%
1-Year Est. Return
60.08%
This Fund
S&P 500
This Quarter
Est. Return
-12.72%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$94M
AUM Growth
-$25.2M
(-21%)
Cap. Flow
-$6.81M
Cap. Flow
% of AUM
-7.25%
Top 10 Holdings %
Top 10 Hldgs %
39.65%
Holding
76
New
5
Increased
32
Reduced
9
Closed
7
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Radiant Logistics
RLGT
|
+$1.19M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
+$1.05M |
| 3 |
Fidelity National Financial
FNF
|
+$1.02M |
| 4 |
Warner Bros
WBD
|
+$927K |
| 5 |
Clear Secure
YOU
|
+$675K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cytokinetics
CYTK
|
+$4.83M |
| 2 |
Expand Energy Corp
EXE
|
+$2.61M |
| 3 |
Intel
INTC
|
+$2.48M |
| 4 |
Barrick Mining
B
|
+$2.39M |
| 5 |
Theravance Biopharma
TBPH
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.57% |
| 2 | Energy | 12.07% |
| 3 | Financials | 12.06% |
| 4 | Industrials | 8.35% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
DELISTED
ARKO Corp Warrant
ARKOW
| $568K | 0.6% |
400,000
| – | – |
2021 Q1
5 quarters
|
|
52
Heron Therapeutics
HRTX
$68.4M
| $558K | 0.59% |
200,000
| – | – |
2020 Q4
6 quarters
|
|
53
Eledon Pharmaceuticals
ELDN
$183M
| $549K | 0.58% |
225,000
| – | – |
2021 Q1
5 quarters
|
|
|
SVC
54
Service Properties Trust
SVC
$762M
| $523K | 0.56% |
20,000
+10,000
| +100% | +$345K |
2021 Q3
3 quarters
|
|
|
55
Clear Secure
YOU
$4.55B
| $500K | 0.53% |
+25,000
| New | +$675K |
2022 Q2
0 quarters
|
|
56
BioCardia
BCDA
$14.1M
| $477K | 0.51% |
21,933
| – | – |
2020 Q4
6 quarters
|
|
57
Nektar Therapeutics
NKTR
$1.26B
| $475K | 0.51% |
8,333
+3,333
| +67% | +$210K |
2020 Q4
6 quarters
|
|
|
SPPI
58
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $468K | 0.5% |
600,000
| – | – |
2020 Q4
6 quarters
|
|
59
Gain Therapeutics
GANX
$57.2M
| $450K | 0.48% |
125,000
| – | – |
2021 Q2
4 quarters
|
|
60
Smith Micro Software
SMSI
$13.1M
| $432K | 0.46% |
4,375
+375
| +9% | +$43.6K |
2020 Q4
6 quarters
|
|
|
BCEL
61
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $403K | 0.43% |
225,000
+75,000
| +50% | +$157K |
2020 Q4
6 quarters
|
|
62
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $389K | 0.41% |
18,500
+2,250
| +14% | +$52.8K |
2021 Q3
3 quarters
|
|
63
inTEST
INTT
$168M
| $375K | 0.4% |
55,000
| – | – |
2020 Q4
6 quarters
|
|
64
Amneal Pharmaceuticals
AMRX
$6.58B
| $318K | 0.34% |
+100,000
| New | +$362K |
2022 Q2
0 quarters
|
|
65
Vornado Realty Trust
VNO
$6B
| $286K | 0.3% |
+10,000
| New | +$357K |
2022 Q2
0 quarters
|
|
66
Lantern Pharma
LTRN
$9.87M
| $258K | 0.27% |
45,100
+11,335
| +34% | +$67.6K |
2022 Q1
1 quarter
|
|
67
Pan American Silver
PAAS
$17.5B
| $197K | 0.21% |
10,000
-20,000
| -67% | -$479K |
2021 Q2
4 quarters
|
|
|
68
Barrick Mining
B
$63.8B
| $177K | 0.19% |
10,000
-110,000
| -92% | -$2.39M |
2020 Q4
6 quarters
|
|
69
Compass Therapeutics
CMPX
$155M
| $80K | 0.09% |
30,000
-270,000
| -90% | -$586K |
2022 Q1
1 quarter
|
|
70
Aterian
ATER
$10.6M
| – | – |
-8,333
| Closed | -$243K | – |
|
71
Garrett Motion
GTX
$4.72B
| – | – |
-90,000
| Closed | -$647K | – |
|
|
72
Intel
INTC
$522B
| – | – |
-50,000
| Closed | -$2.48M | – |
|
73
Newell Brands
NWL
$2.32B
| – | – |
-20,000
| Closed | -$428K | – |
|
74
Relmada Therapeutics
RLMD
$342M
| – | – |
-15,000
| Closed | -$405K | – |
|
|
75
DELISTED
Theravance Biopharma
TBPH
| – | – |
-120,000
| Closed | -$1.15M | – |
|
Similar funds
SFSG
PTFIS
AWMG
LDNAM
DFS
APW
GA
TC
CM Management's Q2 2022 Portfolio in Review
As of Q2 2022, CM Management held 76 positions worth $94M, down 21% from $119M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
CM Management withdrew a net $6.81M in Q2 2022, closing 7 positions and reducing 9 holdings. Its most notable exit was Expand Energy Corp, an estimated $2.61M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Energy and Financials.
Against the trend, CM Management opened a new position in Fidelity National Financial worth $924K.
- CM Management's largest Q2 2022 buy was Fidelity National Financial: 26,000 shares worth $924K.
- CM Management added most to Radiant Logistics in Q2 2022, an estimated $1.19M increase.
- CM Management's biggest Q2 2022 reduction was Cytokinetics, cutting an estimated $4.83M.
- CM Management fully exited Expand Energy Corp in Q2 2022, selling an estimated $2.61M.
- CM Management's ten largest holdings make up 40% of its $94M portfolio in Q2 2022.
- CM Management opened 5 new positions and closed 7 in Q2 2022.
- CM Management's portfolio value fell 21% quarter-over-quarter to $94M.
Based on CM Management's 13F filing for Q2 2022, filed 8 Aug 2022.